chr3-148991642-T-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PS1_ModeratePM2
The NM_004130.4(GYG1):c.2T>A(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000323 in 1,547,736 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000029 ( 0 hom. )
Consequence
GYG1
NM_004130.4 start_lost
NM_004130.4 start_lost
Scores
4
7
5
Clinical Significance
Conservation
PhyloP100: 0.884
Genes affected
GYG1 (HGNC:4699): (glycogenin 1) This gene encodes a member of the glycogenin family. Glycogenin is a glycosyltransferase that catalyzes the formation of a short glucose polymer from uridine diphosphate glucose in an autoglucosylation reaction. This reaction is followed by elongation and branching of the polymer, catalyzed by glycogen synthase and branching enzyme, to form glycogen. This gene is expressed in muscle and other tissues. Mutations in this gene result in glycogen storage disease XV. This gene has pseudogenes on chromosomes 1, 8 and 13 respectively. Alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_004130.4 (GYG1) was described as [Likely_pathogenic] in ClinVar as 1477393
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GYG1 | NM_004130.4 | c.2T>A | p.Met1? | start_lost | 1/8 | ENST00000345003.9 | |
GYG1 | NM_001184720.2 | c.2T>A | p.Met1? | start_lost | 1/7 | ||
GYG1 | NM_001184721.2 | c.2T>A | p.Met1? | start_lost | 1/6 | ||
GYG1 | XM_017006275.2 | c.-40T>A | 5_prime_UTR_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GYG1 | ENST00000345003.9 | c.2T>A | p.Met1? | start_lost | 1/8 | 1 | NM_004130.4 |
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151308Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
151308
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000669 AC: 1AN: 149492Hom.: 0 AF XY: 0.0000121 AC XY: 1AN XY: 82668
GnomAD3 exomes
AF:
AC:
1
AN:
149492
Hom.:
AF XY:
AC XY:
1
AN XY:
82668
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000286 AC: 4AN: 1396428Hom.: 0 Cov.: 30 AF XY: 0.00000434 AC XY: 3AN XY: 690992
GnomAD4 exome
AF:
AC:
4
AN:
1396428
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
690992
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151308Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 73932
GnomAD4 genome
AF:
AC:
1
AN:
151308
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
73932
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Glycogen storage disease XV;C4015452:Polyglucosan body myopathy type 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1508529). Disruption of the initiator codon has been observed in individual(s) with GYG1-related conditions (PMID: 27544502). This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change affects the initiator methionine of the GYG1 mRNA. The next in-frame methionine is located at codon 47. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D;D;D
PROVEAN
Uncertain
D;.;D;D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;.;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D;D
Polyphen
P;D;D;D;.;.
Vest4
MutPred
Gain of ubiquitination at M1 (P = 0.0267);Gain of ubiquitination at M1 (P = 0.0267);Gain of ubiquitination at M1 (P = 0.0267);Gain of ubiquitination at M1 (P = 0.0267);Gain of ubiquitination at M1 (P = 0.0267);Gain of ubiquitination at M1 (P = 0.0267);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at